BAX
Ticker
Baxter International Inc
Company
Devices
Industry
Healthcare
Sector
Financial Ratio Analysis
+
2009
+
2010
+
2011
+
2012
+
2013
+
2014
+
2015
+
2016
+
2017
+
2018
+
2019
+
2020
+
2021
+
2022
+
2023
+
2024
+
2025
TTM
Revenue Growth YoY
β€”2.2%8.2%2.1%7.5%9.3%-40.2%2.0%3.9%5.1%2.4%2.7%9.5%13.5%2.1%-28.2%β€”-6.3%
Revenue Growth QoQ
β€”2.2%8.2%2.1%7.5%9.3%-40.2%2.0%3.9%5.1%2.4%2.7%9.5%13.5%2.1%-28.2%β€”β€”
Gross Margin
51.9%46.4%50.7%51.5%49.8%48.9%41.6%40.4%42.2%42.9%41.9%39.3%39.9%34.9%33.6%37.5%β€”34.1%
EBITDA Margin
28.0%22.0%26.0%24.9%22.9%22.3%12.1%15.0%19.1%21.2%22.5%20.9%20.3%-5.9%11.2%9.5%β€”8.8%
Operating Margin
22.9%16.6%21.2%19.9%17.5%16.2%4.5%7.1%11.9%14.3%15.6%13.8%13.4%-15.5%2.6%0.1%β€”-0.1%
Profit Margin
17.6%11.1%16.0%16.4%13.2%15.0%9.7%48.9%6.8%13.9%8.8%9.4%10.0%-16.8%17.9%-6.1%β€”-3.1%
FCF / EBITDA
53.9%72.3%51.4%55.1%47.9%35.5%71.2%61.4%59.6%57.7%55.0%47.5%56.9%-68.5%62.6%56.7%β€”25.1%